Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completed

Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma

NCT01926990
unknownnot_applicable

Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma

NCT03754192
completednot_applicable

The Use of Perfusion CT Derived Parameters as Early Acute Pancreatitis Severity Biomarker Compared to Clinico Biological Score

NCT03456557

Clinical Trials (3)

Showing 3 of 3 trials
NCT01926990

Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma

Completed
NCT03754192Not Applicable

Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma

Unknown
NCT03456557Not Applicable

The Use of Perfusion CT Derived Parameters as Early Acute Pancreatitis Severity Biomarker Compared to Clinico Biological Score

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3